More than a week after the Centers for Disease Control and Prevention and the Food and Drug Administration recommended a pause on the one-shot Johnson & Johnson vaccine due to reports of severe blood clots, a government advisory committee will meet again Friday to discuss next steps. I want this vaccine back as soon as possible, said Dr. Amesh Adalja, an infectious disease expert and senior scholar with the Johns Hopkins University Center for Health Security. I was recommending it preferentially to my friends. One and done.
The vaccine was paused after reports of a rare combination of blood clots and low levels of platelets within two weeks of vaccination in six women out of the more than 7 million Americans who recently got the J&J shot, and one man from an earlier clinical trial. One of the women died, and another is hospitalized in critical condition.
South-africa
Oregon
United-states
Texas
Carbondale
California
Carbondale-elementary-school
Colorado
Shelby-county
Canada
Michigan
Riverside-county